[Possibility of in vivo formation of N-nitroso compounds from drugs and nitrite (author's transl)].
D000284:Administration, Oral; D000818:Animals; D001205:Ascorbic Acid; D002273:Carcinogens / Q000378:metabolism; D004347:Drug Interactions; D005753:Gastric Mucosa / Q000378:metabolism; D006801:Humans; D051379:Mice; D009153:Mutagens / Q000378:metabolism; D009369:Neoplasms / Q000139:chemically induced; D009573:Nitrites / Q000008:administration & dosage / Q000378:metabolism*; D009603:Nitroso Compounds / Q000378:metabolism*; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011817:Rabbits; D051381:Rats
D002273:Carcinogens; D009153:Mutagens; D009573:Nitrites; D009603:Nitroso Compounds; D004364:Pharmaceutical Preparations; D001205:Ascorbic Acid